Results 1 to 10 of about 754,759 (237)

Dengue vaccines: closer but not there yet [PDF]

Memórias do Instituto Oswaldo Cruz, 2011
Galler, Ricardo, Bonaldo, Myrna Cristina, Alves, Ada Maria de Barcelos   +2 more
openaire   +4 more sources

Optimizing dengue vaccination strategies. [PDF]

PLoS Med
Wilder-Smith A.
europepmc   +1 more source

Intention to Receive the TAK-003 Dengue Vaccine and Associated Factors Among Adults in Rural Northern Thailand. [PDF]

Vaccines (Basel)
Polpitakchai C, Pangprasertkul S, Rusmevichientong P, Yamsiri R, Panumasvivat J, Sirikul W, Sapbamrer R, Luo S, Lin C, Kitro A.   +9 more
europepmc   +1 more source

The need for balanced dengue vaccine protection: Insights from Thai surveillance data on four serotypes. [PDF]

PLoS Negl Trop Dis
Khosavanna RR, Iamsirithaworn S, Pinpaiboon S, Phutthasophit K, Hunsawong T, Ko AI, Anderson KB, Buddhari D.   +7 more
europepmc   +1 more source

Editorial for Special Issue "Molecular Research in Vaccinology and Vaccine Development". [PDF]

Curr Issues Mol Biol
Farsang A.
europepmc   +1 more source

Dengue vaccine acceptability in Peru: A mixed-methods study in two dengue-endemic Peruvian cities. [PDF]

PLoS Negl Trop Dis
Cañari-Casaño JL, Ortega EB, Vizcarra AS, Camizan-Castro R, Ríos López EJ, Córdova López JJ, Hidalgo C, Moyano LM, Morrison AC, Paz-Soldan VA.   +9 more
europepmc   +1 more source

Author Correction: The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine. [PDF]

NPJ Vaccines
Escudero I, Gniel D, Biswal S, Petri E, Perez G, Sharma M, Weil J, Wallace D.   +7 more
europepmc   +1 more source

Research progress of dengue virus T cell epitope mediated cellular immunity in avoiding ADE. [PDF]

Front Immunol
Ma M, Ye P, Pan J, Zhang Y, Yan W, Xu B, Ding J, Jiang L.   +7 more
europepmc   +1 more source

Approaches to quantifying acceptability of pharmaceutical interventions for neglected tropical diseases: A scoping review. [PDF]

PLoS Negl Trop Dis
Duguay C, Ost K, Krentel A.
europepmc   +1 more source

COVID-19 Virus Infection and Transmission are Observably Less in Highly Dengue-endemic Countries: Can Dengue Vaccines be “Repurposed” to Prevent COVID-19?

, 2020
Biswas S, Sukla S.
europepmc   +1 more source